ArticleLung cancer (Amsterdam, Netherlands)2020

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer.

Xiaoke Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.